A detailed history of Stonnington Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stonnington Group, LLC holds 4,465 shares of LLY stock, worth $3.55 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
4,465
Previous 7,466 40.2%
Holding current value
$3.55 Million
Previous $2.73 Million 43.87%
% of portfolio
0.4%
Previous 0.77%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023

SELL
$310.63 - $364.82 $932,200 - $1.09 Million
-3,001 Reduced 40.2%
4,465 $1.53 Million
Q4 2022

Jan 11, 2023

BUY
$321.55 - $374.67 $323,479 - $376,918
1,006 Added 15.57%
7,466 $0
Q3 2022

Oct 20, 2022

BUY
$296.48 - $337.87 $318,716 - $363,210
1,075 Added 19.96%
6,460 $2.13 Million
Q2 2022

Jul 08, 2022

BUY
$278.73 - $327.27 $884,967 - $1.04 Million
3,175 Added 143.67%
5,385 $1.77 Million
Q1 2022

Apr 12, 2022

SELL
$234.69 - $291.66 $3.81 Million - $4.74 Million
-16,235 Reduced 88.02%
2,210 $683,000
Q4 2021

Jan 12, 2022

BUY
$224.85 - $279.04 $3.55 Million - $4.41 Million
15,810 Added 600.0%
18,445 $4.84 Million
Q4 2021

Jan 12, 2022

BUY
$224.85 - $279.04 $120,294 - $149,286
535 Added 25.48%
2,635 $691,000
Q3 2021

Oct 12, 2021

SELL
$221.6 - $272.71 $28,143 - $34,634
-127 Reduced 5.7%
2,100 $491,000
Q2 2021

Jul 09, 2021

SELL
$180.55 - $233.54 $550,677 - $712,297
-3,050 Reduced 57.8%
2,227 $528,000
Q1 2021

May 21, 2021

BUY
$164.32 - $212.72 $867,116 - $1.12 Million
5,277 New
5,277 $1.02 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.